Latest News for: ci protein

Edit

ADULT PATIENTS IN SCOTLAND WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH STAGE 1 AND 2 POLYNEUROPATHY CAN NOW ACCESS ASTRAZENCA’S WAINZUA™▼(EPLONTERSEN)

Pharmiweb 07 Apr 2025
... from baseline in the external placebo group (difference, -70.4% [95% CI, -75.2% to -65.7%]; p<0.001].2 Results showed that eplontersen reduced serum TTR protein levels as early as week 5.2.
  • 1
×